Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-069944

Options or other derivatives

  • VP - Research acquired 34,020 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RIOS MIGUEL DE LOS · VP - Research

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-11-18 Grant or award : show line 1 in the form Common Stock Option (right to buy) +34,020 147,102 D
Loading xslF345X03/form471633_20141120093158-.xml…